# OnCo record paper-gotlib-midostaurin-advanced-systemic-mastocytosis-nejm-2016 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-gotlib-midostaurin-advanced-systemic-mastocytosis-nejm-2016/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-gotlib-midostaurin-advanced-systemic-mastocytosis-nejm-2016" ;
  schema:name "Efficacy and safety of midostaurin in advanced systemic mastocytosis"@en ;
  schema:description "The multi-kinase inhibitor midostaurin shrank the mast cell burden and reversed organ damage in six in ten patients with advanced systemic mastocytosis, becoming the first approved targeted drug for the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-gotlib-midostaurin-advanced-systemic-mastocytosis-nejm-2016/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1513098>, <https://pubmed.ncbi.nlm.nih.gov/27355533/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1513098> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Gotlib J, Kluin-Nelemans HC, George TI, et al." ;
  onco:cancers <https://onco.cc/cancers/advanced-systemic-mastocytosis/> ;
  onco:drugs <https://onco.cc/drugs/midostaurin/> ;
  onco:journals <https://onco.cc/journals/nejm/> .
